—
C+
C+ The full Closelook — membership. Open the C+ overview

Sanofi SA (SAN.PA) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Sanofi SA

SAN.PA in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Sanofi researches, develops and manufactures medicines and vaccines, covering immunology, rare diseases, neurology, oncology and other therapeutic areas. Its vaccine business includes childhood shots for polio, pertussis and Hib, plus respiratory syncytial virus protection and combination vaccines against hepatitis, typhoid, yellow fever and rabies. The company also runs a wide set of research collaborations with smaller biotech and AI-drug-discovery partners to widen its pipeline. Sanofi is headquartered in Paris, France.
Where it sits in the stack
Sanofi carries no seat in Rubin or Halo, so it sits outside the diary's AI build-out stack; it belongs to the Healthcare sector of our wider universe.
Who it is priced against
Closelook's peer group places it with scored healthcare names in the same sector, including Argen-X, Eli Lilly, Medpace, BeiGene, UCB, Fisher & Paykel Healthcare and Globus Medical; the market also compares it with Novartis.
Why Closelook tracks it
Sanofi holds a seat in our Euro-AI 50 index and carries a Closelook score, with quality the strongest module and momentum the weakest.
What the diary watches
The diary watches whether the pipeline built through its many research collaborations turns into stronger growth, given how far growth trails quality in its current score.

Sanofi SA (SAN.PA) trades on the PA exchange in France, classified under Healthcare. Constituent of Euro-AI 50.

The Closelook company score reads 57/100 composite (momentum 45, quality 68, valuation 65) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for SAN.PA, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Healthcare · 8 names with week and year-to-date

Peer group

Healthcare

Scored names in the same sector from the Closelook universe.

Compared against SAN.PA on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Versus its index Euro-AI 50 — the name, its sleeve and the index over day, week and month

Versus its index

The name against its Closelook index and its own sleeve — equal-weight, nightly closes.

Euro-AI 50 · as of 2026-09-17

DayWeekMonth3 months
SAN.PA0.0%+0.9%−4.5%+0.1%
Euro-AI 50+1.7%+0.9%−4.1%—

Against the index: in line on the week, 0.4 pts behind on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sector × region Health care in Europe: +1.1% week · −3.6% month · +0.3% quarter · −6.5% yearThe Sector Engine cell this name lives in, from EXV4.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-16
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Sanofi SA (SAN.PA)?

Sanofi SA trades as SAN.PA on the PA exchange (France) and is classified under Healthcare in the Closelook research universe, as of the registry build of 2026-09-18.

Is SAN.PA in a Closelook index?

Yes — Sanofi SA is a constituent of Euro-AI 50, as of 2026-09-18.

What is Sanofi SA's Closelook composite score?

57 out of 100, with momentum 45, quality 68 and valuation 65 sub-scores, as of 2026-09-18. Scores are Closelook's own research readings, not ratings or investment advice.

Where does SAN.PA trade against its moving averages?

In a correction — 12.8% off its high: 12.8% below its 52-week high and under its 50-day — a textbook 10-to-20% correction. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

How is SAN.PA doing against its Closelook index?

Over the past month Sanofi SA is −4.5% against −4.1% for the Euro-AI 50 — 0.4 points behind its index, as of 2026-09-17. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

What does Sanofi SA do?

Sanofi researches, develops and manufactures medicines and vaccines, covering immunology, rare diseases, neurology, oncology and other therapeutic areas. Its vaccine business includes childhood shots for polio, pertussis and Hib, plus respiratory syncytial virus protection and combination vaccines against hepatitis, typhoid, yellow fever and rabies. The company also runs a wide set of research collaborations with smaller biotech and AI-drug-discovery partners to widen its pipeline. Closelook's peer group places it with scored healthcare names in the same sector, including Argen-X, Eli Lilly, Medpace, BeiGene, UCB, Fisher & Paykel Healthcare and Globus Medical; the market also compares it with Novartis.

Where does Sanofi SA sit in the AI build-out?

Sanofi carries no seat in Rubin or Halo, so it sits outside the diary's AI build-out stack; it belongs to the Healthcare sector of our wider universe. Sanofi holds a seat in our Euro-AI 50 index and carries a Closelook score, with quality the strongest module and momentum the weakest.

What does this page show?

A live price chart with SMA overlays and drawing tools for SAN.PA, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe